An Apoferritin-Hemagglutinin Conjugate Vaccine with Encapsulated Nucleoprotein Antigen Peptide from Influenza Virus Confers Enhanced Cross Protection | |
Wei, Jiangxue1,2; Li, Zhengjun1; Yang, Yanli1; Ma, Guanghui1; Su, Zhiguo1; Zhang, Songping1 | |
刊名 | BIOCONJUGATE CHEMISTRY |
2020-08-19 | |
卷号 | 31期号:8页码:1948-1959 |
ISSN号 | 1043-1802 |
DOI | 10.1021/acs.bioconjchem.0c00308 |
英文摘要 | Naturally occurring self-assembling ferritin nanoparticles have become widely appreciated for vaccine design. In this study, an apoferritin (AFt) nanocage was used as a carrier to construct a biomimetic influenza vaccine by encapsulating a conserved internal nucleoprotein (NP) antigen peptide inside the nanocage, followed by chemically conjugating the surface antigen hemagglutinin (HA) protein on the outer surface of the AFt. Benefiting from the excellent thermal stability and thermallyassociated structural flexibility of the AFt nanocages, a novel temperature shift based encapsulation process was proposed and proved efficient for encapsulation of the NP peptides. On average, about 18 NPs were encapsulated and 1.6 HA antigens were conjugated in each of the HA-AFt+NP dual-antigen influenza vaccines. Upon immunization in mice, the HA-AFt+NP vaccine elicited both HA and NP-specific antibodies, and conferred complete protection against a lethal infection of both homologous PR8 H1N1 and heterologous A/FM/1/47 (FM1, H1N1) strains, while the HA-AFt conjugate vaccine without encapsulated NP antigen only conferred 60% protection against the FM1 H1N1 viral challenge. The potential cross-protective effect of the HA-AFt+NP vaccine was further demonstrated by significant specific hemagglutination inhibition (HAI) titers in serum of the immunized mice against heterologous A/Hong Kong/4801/2014 (H3N2) viral strain, which was about 3-fold of that induced by HA antigen and 2-fold of the HA-AFt conjugate vaccine. This biomimetic HA-AFt+NP conjugate vaccine, therefore, may represent a new strategy for developing a potential universal influenza vaccine without the need of any adjuvant, and further broaden the application of AFt nanocages in the areas of vaccine development and delivery system. |
资助项目 | National Natural Science Foundation of China[21821005] ; National Natural Science Foundation of China[31970872] ; National Natural Science Foundation of China[21808226] |
WOS关键词 | Horse-spleen Apoferritin ; Nanoparticle Vaccines ; Cage Nanoparticles ; Ferritin ; Cell ; Immunogenicity ; Antibodies ; Stability ; Immunity ; Design |
WOS研究方向 | Biochemistry & Molecular Biology ; Chemistry |
语种 | 英语 |
出版者 | AMER CHEMICAL SOC |
WOS记录号 | WOS:000563069900010 |
资助机构 | National Natural Science Foundation of China |
内容类型 | 期刊论文 |
源URL | [http://ir.ipe.ac.cn/handle/122111/41783] |
专题 | 中国科学院过程工程研究所 |
通讯作者 | Su, Zhiguo; Zhang, Songping |
作者单位 | 1.Chinese Acad Sci, Inst Proc Engn, State Key Lab Biochem Engn, Beijing 100190, Peoples R China 2.Univ Chinese Acad Sci, Beijing 100049, Peoples R China |
推荐引用方式 GB/T 7714 | Wei, Jiangxue,Li, Zhengjun,Yang, Yanli,et al. An Apoferritin-Hemagglutinin Conjugate Vaccine with Encapsulated Nucleoprotein Antigen Peptide from Influenza Virus Confers Enhanced Cross Protection[J]. BIOCONJUGATE CHEMISTRY,2020,31(8):1948-1959. |
APA | Wei, Jiangxue,Li, Zhengjun,Yang, Yanli,Ma, Guanghui,Su, Zhiguo,&Zhang, Songping.(2020).An Apoferritin-Hemagglutinin Conjugate Vaccine with Encapsulated Nucleoprotein Antigen Peptide from Influenza Virus Confers Enhanced Cross Protection.BIOCONJUGATE CHEMISTRY,31(8),1948-1959. |
MLA | Wei, Jiangxue,et al."An Apoferritin-Hemagglutinin Conjugate Vaccine with Encapsulated Nucleoprotein Antigen Peptide from Influenza Virus Confers Enhanced Cross Protection".BIOCONJUGATE CHEMISTRY 31.8(2020):1948-1959. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论